Digital prescription platforms expanding access in the Veterinary Anti-infectives Market

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Antiviral Combination Therapy Market During The Forecast Period 2026–2030?

The veterinary anti-infectives market has demonstrated substantial growth in recent years. It is anticipated to expand from $6.02 billion in 2025 to $6.59 billion in 2026, at a compound annual growth rate (CAGR) of 9.6%. This historical expansion can be attributed to several factors, including the increasing occurrence of livestock diseases, a rising companion animal population, the long-standing reliance on antibiotics, greater veterinary awareness, and the proliferation of veterinary clinics, particularly in the Asia-Pacific region.

The veterinary anti-infectives market is projected for significant expansion over the coming years, with its value expected to reach $9.53 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. This growth in the forecast period is fueled by factors such as a rising demand for precision veterinary medicines, the increasing adoption of antiviral and antifungal agents, a heightened focus on preventive healthcare, the expansion of veterinary hospitals and pharmacies, and the development of immune modulators and advanced disinfectants. Noteworthy trends during this time include the increasing use of antibiotics and antimicrobial agents, the rising adoption of vaccines and antiviral medications, a growing awareness of animal disease prevention, the expansion of the companion animal healthcare market, and a surging demand for topical and systemic antifungal treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7802&type=smp

Which Economic Or Industry Drivers Are Impacting The Antiviral Combination Therapy Market?

The growth of the veterinary anti-infectives market is projected to be propelled by an escalation in pet ownership. Pet ownership encompasses having a dog, cat, or another domestic animal at home. The increasing adoption of pets stems from a rising proportion of the young population regarding them as family members, with some owners also embracing them for their companionship, faithfulness, and as a means to counteract loneliness. Veterinary anti-infectives play a vital role in supporting pet ownership by effectively preventing and managing infections in animals, which ensures their health and minimizes the likelihood of illness for both pets and their owners. Illustratively, in 2023, figures from Shelter Animals Count, a US-based non-governmental organization, revealed that the animal sheltering system nationwide accommodated an additional 177,000 dogs and cats compared to the same timeframe in 2022. Thus, the expansion of pet ownership is fueling the demand for the veterinary anti-infectives market.

What Market Segments Are Evaluated Within The Antiviral Combination Therapy Market?

The veterinary anti-infectives market covered in this report is segmented –

1) By Drug Class: Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes

2) By Species Type: Livestock Animals, Companion Animals

3) By Mode Of Administration: Oral, Parenteral, Topical

4) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies, Other Distribution Channels

Subsegments:

1) By Antimicrobial Agents: Antibiotics, Antiseptics

2) By Antiviral Agents: Vaccines, Antiviral Medications

3) By Antifungal Agents: Topical Antifungals, Systemic Antifungals

4) By Other Drug Classes: Parasiticides, Immune Modulators, Disinfectants

What Industry Trends Are Redefining The Veterinary Anti-infectives Market?

Leading companies within the veterinary anti-infectives market are utilizing sophisticated technologies to sustain their competitive standing. These advanced technologies refer to innovative methods and tools that improve the prevention, diagnosis, and treatment of infections in animals, enhancing their effectiveness and safety. For instance, in May 2025, Amazon.com Inc., a US-based e-commerce and pharmacy services provider, launched expanded pet prescription medication offerings in partnership with Strategic Pharmaceutical Solutions Inc. (Vetsource), a US-based leading veterinary technology and pharmacy platform. This allows customers to order veterinarian-approved anti-infective and other prescriptions online, provides delivery typically within two to six days, and simplifies refill approvals through digital checkout integration and veterinarian verification. This innovation broadens access and enhances client engagement but may require careful integration with clinical workflows and adherence to regulatory standards.

Who Are The Top Market Participants Influencing The Antiviral Combination Therapy Market?

Major companies operating in the veterinary anti-infectives market are Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

Read the full veterinary anti-infectives market report here:

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

What Are The Top-Performing Regions Within The Antiviral Combination Therapy Market?

North America was the largest region in the veterinary anti-infectives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Antiviral Combination Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7802&type=smp

Browse Through More Reports Similar to the Global Veterinary Anti-infectives Market 2026, By The Business Research Company

Animal Antibiotics And Antimicrobials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

Veterinary Antibiotics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795